Skip to content

MDMA: all studies

Page 19 of 345: studies 181 to 190 of 3,446, newest first. Back to the MDMA overview

Research

Pre-exposure to eutylone attenuates its own aversive effects but has no impact on cocaine or MDMA: A possible role of eutylone's hybrid pharmacology.

Pharmacology, Biochemistry, and Behavior July 1, 2025 Negar G Ardabili, Shira Tan, Anthony L Riley 1 citation

Previous research has reported that pre-exposure to a variety of drugs of abuse can impact (reduce) the aversive effects of themselves and other abused compounds, often as a function of their shared pharmacological activity. In this context, the present series of studies investigated the effects of history with the synthetic cathinone eutylone on the aversive effects of cocaine, MDMA, and...

DOI: 10.1016/j.pbb.2025.174013 (opens in new tab) Full text (opens in new tab) MDMA Cocaine Conditioned taste avoidance Drug pre-exposure +8

Meta-Analysis on Predatory Date-Rape Drugs: Pharmacodynamics and Counteractive Studies of Liquid Ecstasy-GHB (y-hydroxybutyrate) and Ecstasy (3, 4-methylenedioxy-N-methamphetamine, or MDMA)

International Journal of Science and Research (IJSR) June 18, 2025 Rajat Ramesh Pithadia, Sheetal Rajan

The purpose of this research is to investigate developing misuse of certain psychotropic substances, depressants, hypnotics & stimulant drugs. The research is intended to generate a uniform understanding over cruel usage of certain drugs; in diminishing attentiveness, reducing senses & disturbing logical / cognitive skills. This guide is essential to understand how predatory drugs initiate...

The Potential Neuroinflammatory Attenuation Effects of Thymoquinone against 3, 4-Methylenedioxymethamphetamine-Induced Microglial Activation in BV2 Mouse Cell Line

bioRxiv Preprint Server June 16, 2025 Nor Suliana Mustafa, Nasir Mohamad, Nor Hidayah Abu Bakar et al. preprint

MDMA induced the activation of microglia in the brain which would lead to neurotoxicity. The activation of microglia is associated with morphological changes and the production of inflammatory phenotypes. While there is research suggesting that thymoquinone (TQ) may have anti-inflammatory effects and modulate microglial activation, studies specifically focusing on its impact on activated...

MDMA-Assisted Treatment for PTSD, Anxiety, and Depression: A Visualized Literature Analysis over 30 Years.

Current Medicinal Chemistry June 2, 2025 Jinlong Zhang, Xingxing Dang, Jiang Lin et al.

The incidence of psychiatric disorders, such as post-traumatic stress disorder (PTSD), anxiety, and depression, has been steadily increasing, while current treatment approaches remain limited in efficacy. As a result, there is an urgent need to explore more effective therapeutic interventions. In recent years, MDMA (3,4- methylenedioxymethamphetamine)-assisted therapy (MDMA-AT) has emerged as a...

Bioproduction of 3,4-methylenedioxymethamphetamine and derivatives.

Biodesign research June 1, 2025 Natali Ozber, Jing Li, Peter J. Facchini 2 citations

3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy) is a recreational drug under clinical investigation for the treatment of central nervous system disorders, including post-traumatic stress disorder. Chemical synthesis of MDMA mainly relies on the use of safrole and piperonal as starting materials. We report a novel strategy integrating bioconversion and biocatalysis in the bioproduction of MDMA...

DOI: 10.1016/j.bidere.2025.100011 (opens in new tab) Full text (opens in new tab) 3,4-methylenedioxymethamphetamine Biocatalysis Bioconversion Synthetic biology +1

Aus dem Nähkästchen: Praxiseinblicke in die Traumatherapie mit MDMA in Australien und der Schweiz

Psychotherapie Forum June 1, 2025 Eva Gallacher, Andrea Jesser

Zusammenfassung Die Psychotherapie mit Unterstützung durch 3,4-Methylendioxymethamphetamin MDMA, in der Öffentlichkeit bekannt als „Ecstasy“, befindet sich aktuell im Zulassungsprozess. Bisherige Studienergebnisse deuten auf eine gute Wirksamkeit MDMA-assistierter Psychotherapien hin. Auf Basis einer Literaturübersicht und vertieft durch Experteninterviews skizziert die vorliegende Arbeit, wie...

Ecstasy as a Potential Cause for Diffuse ST Elevation in a 27-Year-Old Healthy Male: A Case Report.

Cureus June 1, 2025 Rabih Nasrallah, Amin Ossaily, Mazen Al Hammoud et al. 2 citations

Ecstasy, also known as 3,4-methylenedioxymethamphetamine (MDMA), is widely used as a recreational drug known for its stimulating effects. While acute coronary syndrome and coronary vasospasm are frequently observed following cocaine and methamphetamine use, there have been few reported cases linking them to ecstasy use. We present a case of a 27-year-old, previously healthy, male presenting...

DOI: 10.7759/cureus.85795 (opens in new tab) Full text (opens in new tab) Acute coronary syndrome Case report Coronary vasospasm Stimulant-related heart problems +11

Discriminative stimulus properties of α-ethyltryptamine (α-ET) in rats: α-ET-like effects of MDMA, MDA and aryl-monomethoxy substituted derivatives of α-ET.

Psychopharmacology June 1, 2025 Carmen Abate, Richard Young, Małgorzata Dukat et al. 2 citations

Rationale α-ET (α-ethyltryptamine), a homolog of the classical hallucinogen α-methyltryptamine, was once prescribed clinically as an antidepressant. Classical psychedelic drugs are currently of interest as potential pharmacotherapy for psychiatric disorders. Objectives Drug discrimination was used to (a) determine if α-ET-like stimulus effects could be engendered by the prototypical...

DOI: 10.1007/s00213-024-06738-y (opens in new tab) Full text (opens in new tab) PTSD Drug discrimination Entactogen Phenylalkylamine +8

The effect of MDMA on anterior pituitary hormones: a secondary analysis of a randomized placebo-controlled trial.

Endocrine connections June 1, 2025 Cihan Atila, Sara-Jessica Camerin, Matthias E. Liechti et al. 2 citations

3,4-Methylenedioxymethamphetamine (MDMA), a psychoactive substance, has been proposed as a novel provocation test for oxytocin deficiency. Limited evidence suggests that MDMA may also stimulate the anterior pituitary. Therefore, this analysis aimed to investigate the acute effect of MDMA on the anterior pituitary in healthy adults. This secondary analysis utilized data from a double-blind,...

Understanding the Psychological Effects of Psilocybin and 3,4-Methylenedioxymethamphetamine in a Non-Clinical Population

medRxiv May 29, 2025 Paul B. Fitzgerald, Sara Webb, Nigel Christopher Denning et al. 2 citations preprint

Abstract Objective Despite many decades of experimental studies and clinical trials involving a variety of psychedelic agents, we still lack a comprehensive understanding of the effects of these substances on psychological experiences. As such, we designed and conducted a study to comprehensively characterise the effects of both psilocybin and 3,4-Methylenedioxymethamphetamine (MDMA) on a range...